Meet ApplyKite Twin, the application assistant that learns with you

Meet your Twin, it learns with you

Your Twin learns with you

Launch week codes:30% off annual Pro20% off monthly Pro

Ends in00h00m00s

John Olynyk

Has grant

Associate Director, Clinical Engagement

Curtin University

Australia

Research Interests

Explore related searches

Professors in Australia

Recent Grants

Grant: Open

Can Aspirin reduce the risk of Hepatocellular Carcinoma (HCC) in subjects with cirrhosis: a multi-centre, placebo-controlled clinical trial

Open Date: 2025-07-01

Close Date: 2030-07-01

Grant: Open

A randomised controlled trial of Standard Of Careversus RadioAblaTion in Early Stage HCC (The SOCRATES HCC Study)

Open Date: 2022-01-01

Close Date: 2028-01-01

Grant: Close

Targeting the TWEAK/Fn14 signalling pathway as a novel therapeutic strategy to prevent chronic liver disease progression

Open Date: 2019-01-01

Close Date: 2022-12-01

Grant: Close

Role of non-transferrin bound iron in iron overload disease

Open Date: 2015-01-01

Close Date: 2017-01-01

Grant: Close

Cellular cross-talk between liver progenitor cells and hepatic stellate cells is required for hepatic fibrogenesis

Open Date: 2015-01-01

Close Date: 2017-01-01

Articles (20)

Year:

2026

Year:

2026

Year:

2026

Year:

2026

Year:

2026

Year:

2026

Year:

2026

Year:

2026

Year:

2026

Year:

2026

Year:

2026

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Collaborators (12)

Nick S. R. Lan

Clinical Senior Lecturer

University of Western Australia

AUSTRALIA

View details

Steven Taylor

South Australian Health and Medical Research Institute

AUSTRALIA

View details

Jonathan Fallowfield

University of Edinburgh

UNITED KINGDOM

View details

Jeremy Shearman

Honorary Associate Clinical Professor

University of Warwick

UNITED KINGDOM

View details

John McNeil

MONASH UNIVERSITY

AUSTRALIA

View details

Benjamin Dwyer

Senior Research Fellow

Curtin University

AUSTRALIA

View details

Simone Strasser

Head of Department

AUSTRALIA

View details

Leon A. Adams

University of Western Australia

AUSTRALIA

View details

Richard Woodman

Flinders University

AUSTRALIA

View details

Sultana Monira Hussain

MONASH UNIVERSITY

AUSTRALIA

View details

Girish Dwivedi

University of Western Australia

AUSTRALIA

View details

Chenglong Yu

MONASH UNIVERSITY

AUSTRALIA

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

John Olynyk

Research Interests

Explore related searches

Recent Grants

Articles (20)

Interplay between PNPLA3 genotype, liver steatosis, and cardiac remodeling in young adults

MASLD coexisting with PCOS increases cardiometabolic risk

Protective potential of minimally processed, plant-derived foods against steatotic liver disease in early adulthood

Delphi expert consensus on phlebotomy limitations and treatment challenges in <i>HFE</i>-related hemochromatosis.

Haemochromatosis - a modern clinician's guide.

Reassessing Ferritin Levels in Healthy Older Adults: Updated Reference Ranges and Associated Health Outcomes

A Supervised, Online, Home-Based Eccentric Resistance Exercise Program for Patients With Metabolic Dysfunction-Associated Steatotic Liver Disease

National survey of real‐world treatment patterns for early‐ and intermediate‐stage hepatocellular carcinoma reveals wide variation across Australian states

Australian best practice recommendations for transjugular intrahepatic portosystemic shunt (TIPS) in portal hypertension: a consensus statement.

HFE and hemochromatosis: time to reconsider the diagnostic role of the p.His63Asp variant

Arthritis and High Alcohol Intake at Diagnosis Increase Future Risk of Hepatocellular Carcinoma in HFE Hemochromatosis

Disease-associated hepatocytes are predictive of outcomes and survival in MASLD beyond fibrosis staging

Haemochromatosis Genotypes and Incident Dementia in a Prospective Study of Older Adults

Abstract 4345579: Once Weekly Utreglutide (GL0034), a Glucagon-like Peptide-1 Receptor Agonist Reduces Liver Fat Content along with Blood Pressure in Post-menopausal Females with Obesity: A Phase 1a/2b Study

Current clinical concerns for patients with hereditary hemochromatosis – a Delphi consensus study

Progress towards "The Treat-All Approach" for hepatitis B.

Exercise Perceptions in People With Metabolic Dysfunction-Associated Steatotic Liver Disease: Insights From a Qualitative Study

Sex-Specific Effects of Hepatic Steatosis on Cardiac Remodelling in Young Adults: Insights From MRI and Implications for Heart Failure Risk

A phase 1b randomised clinical trial evaluating BBI-001, a non-absorbed oral therapeutic for the treatment of iron overload.

Risk profiling for cirrhosis and hepatocellular carcinoma in HFE hemochromatosis using mobilizable iron stores and alcohol consumption.

Collaborators (12)

Nick S. R. Lan

Steven Taylor

Jonathan Fallowfield

Jeremy Shearman

John McNeil

Benjamin Dwyer

Simone Strasser

Leon A. Adams

Richard Woodman

Sultana Monira Hussain

Girish Dwivedi

Chenglong Yu

Make your next move.

John Olynyk

Research Interests

Explore related searches

Recent Grants

Articles (20)

Interplay between PNPLA3 genotype, liver steatosis, and cardiac remodeling in young adults

MASLD coexisting with PCOS increases cardiometabolic risk

Protective potential of minimally processed, plant-derived foods against steatotic liver disease in early adulthood

Delphi expert consensus on phlebotomy limitations and treatment challenges in &lt;i&gt;HFE&lt;/i&gt;-related hemochromatosis.

Haemochromatosis - a modern clinician's guide.

Reassessing Ferritin Levels in Healthy Older Adults: Updated Reference Ranges and Associated Health Outcomes

A Supervised, Online, Home-Based Eccentric Resistance Exercise Program for Patients With Metabolic Dysfunction-Associated Steatotic Liver Disease

National survey of real‐world treatment patterns for early‐ and intermediate‐stage hepatocellular carcinoma reveals wide variation across Australian states

Australian best practice recommendations for transjugular intrahepatic portosystemic shunt (TIPS) in portal hypertension: a consensus statement.

HFE and hemochromatosis: time to reconsider the diagnostic role of the p.His63Asp variant

Arthritis and High Alcohol Intake at Diagnosis Increase Future Risk of Hepatocellular Carcinoma in HFE Hemochromatosis

Disease-associated hepatocytes are predictive of outcomes and survival in MASLD beyond fibrosis staging

Haemochromatosis Genotypes and Incident Dementia in a Prospective Study of Older Adults

Abstract 4345579: Once Weekly Utreglutide (GL0034), a Glucagon-like Peptide-1 Receptor Agonist Reduces Liver Fat Content along with Blood Pressure in Post-menopausal Females with Obesity: A Phase 1a/2b Study

Current clinical concerns for patients with hereditary hemochromatosis – a Delphi consensus study

Progress towards "The Treat-All Approach" for hepatitis B.

Exercise Perceptions in People With Metabolic Dysfunction-Associated Steatotic Liver Disease: Insights From a Qualitative Study

Sex-Specific Effects of Hepatic Steatosis on Cardiac Remodelling in Young Adults: Insights From MRI and Implications for Heart Failure Risk

A phase 1b randomised clinical trial evaluating BBI-001, a non-absorbed oral therapeutic for the treatment of iron overload.

Risk profiling for cirrhosis and hepatocellular carcinoma in HFE hemochromatosis using mobilizable iron stores and alcohol consumption.

Collaborators (12)

Nick S. R. Lan

Steven Taylor

Jonathan Fallowfield

Jeremy Shearman

John McNeil

Benjamin Dwyer

Simone Strasser

Leon A. Adams

Richard Woodman

Sultana Monira Hussain

Girish Dwivedi

Chenglong Yu

Make your next move.

Delphi expert consensus on phlebotomy limitations and treatment challenges in <i>HFE</i>-related hemochromatosis.